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Abstract
Analysis of the genome sequences of the major human bacterial pathogens has provided a large amount of information
concerning their metabolic potential. However, our knowledge of the actual metabolic pathways and metabolite fluxes
occurring in these pathogens under infection conditions is still limited. In this study, we analysed the intracellular carbon
metabolism of enteroinvasive Escherichia coli (EIEC HN280 and EIEC 4608-58) and Salmonella enterica Serovar Typhimurium
(Stm 14028) replicating in epithelial colorectal adenocarcinoma cells (Caco-2). To this aim, we supplied [U-13C6]glucose to
Caco-2 cells infected with the bacterial strains or mutants thereof impaired in the uptake of glucose, mannose and/or
glucose 6-phosphate. The 13C-isotopologue patterns of protein-derived amino acids from the bacteria and the host cells
were then determined by mass spectrometry. The data showed that EIEC HN280 growing in the cytosol of the host cells, as
well as Stm 14028 replicating in the Salmonella-containing vacuole (SCV) utilised glucose, but not glucose 6-phosphate,
other phosphorylated carbohydrates, gluconate or fatty acids as major carbon substrates. EIEC 4608-58 used C3-
compound(s) in addition to glucose as carbon source. The labelling patterns reflected strain-dependent carbon flux via
glycolysis and/or the Entner-Doudoroff pathway, the pentose phosphate pathway, the TCA cycle and anapleurotic reactions
between PEP and oxaloacetate. Mutants of all three strains impaired in the uptake of glucose switched to C3-substrate(s)
accompanied by an increased uptake of amino acids (and possibly also other anabolic monomers) from the host cell.
Surprisingly, the metabolism of the host cells, as judged by the efficiency of 13C-incorporation into host cell amino acids,
was not significantly affected by the infection with either of these intracellular pathogens.
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Introduction
Enteroinvasive Escherichia coli (EIEC), highly related to Shigella
species [1], and Salmonella enterica Serovar Typhimurium (abbre-
viated S. Typhimurium in the following) are typical intracellular
pathogens, causing bloody diarrhoea and gastroenteritis, respec-
tively, in humans [2]. Both microorganisms are mainly food-borne
pathogens and hence reach their target cells after crossing the
intestinal epithelium. In the infected host cells, EIEC similar as
Shigella escapes from the primary phagosome into the cytosol [3],
whereas S. Typhimurium remains in a specialized phagosomal
compartment [4], termed Salmonella-containing vacuole (SCV).
EIEC/Shigella and S. Typhimurium are typical heterotrophic
and prototrophic bacteria. The genome sequences [5,6] show that
these pathogens share a rather similar metabolic setting including
all genes for the major central metabolic pathways, i.e. for
glycolysis, the Entner-Doudoroff pathway, the pentose phosphate
cycle, the citrate (TCA) cycle, the biosyntheses for all amino acids,
as well as for the main anapleurotic reactions including the
glyoxylate shunt. Accordingly, both pathogens grow in vitro under
similar conditions. Glucose is a preferred carbon source for
growth, taken up by EIEC/Shigella and S. Typhimurium mainly by
the two PEP-dependent phosphotransferase systems (PTS), PtsG/
Crr and ManXYZ [7]. Glucose 6-phosphate (glucose-6P) can also
be taken up by both pathogens via highly homologous UhpT
transporters [8]. In both enterobacteria, the uhpT gene is under the
control of a complex two-component system (uhpABC) [9] and
carbon catabolite repression (CCR). Transcription of uhpT is
therefore very low in the presence of glucose. Both pathogens are
able to catabolise various C2-, C3-, C4- and C5-substrates and,
hence, fatty acids, glycerol, pyruvate, lactate and C4-dicarbox-
ylates may also be possible carbon substrates under certain
conditions including growth within mammalian host cells.
First information on the intracellular carbon metabolism of
Shigella and S. Typhimurium came from studies using various in
vivo expression technologies (IVET), differential gene expression
profiling (DGEP) and animal infection experiments with mutants
defective in specific catabolic or anabolic reactions [10,11]. These
studies show that in cytosolically growing Shigella flexneri the genes
encoding the glucose transporters (ptsG/crr and manXYZ) are
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repressed, while those of uhpT, glpF and ugp encoding transporters
for glucose-6P, glycerol and glycerol 3-phosphate, respectively, are
induced. The glycolysis genes are down-regulated, while those for
gluconeogenesis (fbp and pps) are up-regulated. These data favour
glycerol and/or glycerol-P as major carbon source for cytosolically
replicating Shigella. The strong virulence attenuation of aroB-D,
guaBA and thyA mutants of S. flexneri defective in the biosyntheses of
aromatic amino acids, guanine and thymidine [12,13,14] further
suggests that these anabolic monomers have to be synthesised by
intracellular Shigella.
In S. Typhimurium replicating in J774 macrophages or HeLa
cells, genes encoding key enzymes for glycolysis and the Entner-
Doudoroff pathway are up-regulated, while most genes for the
enzymes of the citrate (TCA) cycle are repressed, favouring C6-
sugars as main carbon source for intracellular metabolism.
Glucose, glucose-6P and gluconate are suggested as possible
carbon substrates [10]. A recent study [15] analyzing the growth of
S. Typhimurium mutants defective in glucose uptake and/or
glycolyis in macrophages and in mice confirms the need of glucose
and glycolysis for intracellular carbon metabolism. In systemically
infected mice where S. Typhimurium mainly replicates in
phagocytic cells, intracellular growth depends on a functional
TCA cycle [16]. Specifically, mutants blocked in either one of the
three successive enzymatic reactions converting succinate to
oxaloacetate are avirulent [17], while mutants blocked in
gluconeogenesis are fully virulent [16]. From these data, it is
concluded that S. Typhimurium grows in mouse phagocytes on a
limited supply of glycolytic carbon sources, presumably glucose
and/or other C6-carbohydrates [17]. Upon systemic infections in
mice, strong attenuation is observed for S. Typhimurium mutants
defective in the production of purines (especially of adenine) and
aromatic amino acids including histidine, while moderate
attenuation is found for pyrimidine and methionine mutants
[18,19,20]. This supports that these anabolic compounds have to
be synthesised in intracellularly replicating S. Typhimurium.
Generally, the quantitative analysis of metabolic pathways and
fluxes is crucial to understand the life style (e.g. nutrient usage) of
pathogenic microorganisms under in vivo conditions, as well as
their metabolic crosstalk with the respective host cells. One of the
most important methods for identifying and quantifying reactions
in central metabolism is steady-state metabolic flux analysis (MFA)
using 13C-labelled precursors (e.g. glucose) [21,22,23,24]. In this
approach, the labelling patterns of stable products (e.g. amino
acids) at isotopic and metabolic steady-state are determined by
NMR and/or gas chromatography coupled to mass spectrometry
(GC-MS). The labelling data are then used as constraints in
calculations of flux rates on the basis of model metabolic networks.
MFA is well established as a tool to analyse carbon metabolism
and metabolite fluxes in bacteria including E. coli typically growing
under chemostat conditions in minimal medium with known
uptake, consumption and utilisation of substrates [25,26,27,28,29].
Since these controlled conditions can hardly be realized in host/
pathogen interactions with undefined multiple nutrient usage, the
same methodology can not be used for determining flux rates in
organismic communities. Nevertheless, 13C-labelling of infected
host cells followed by a model-free analysis of the 13C-label
distribution in metabolites from intracellular bacteria and their
respective host cells can provide substantial information about the
nutrient usage and metabolic reactions occurring during infection.
We have termed this observation-driven procedure ‘‘13C-isotopo-
logue profiling’’. The applicability and power, but also the
limitations of 13C-isotopologue profiling have been shown recently
in a study of the carbon metabolism of Listeria monocytogenes
replicating within macrophage cells [30].
In this report, we use 13C-isotopologue profiling to study the
intracellular carbon metabolism of enteroinvasive E. coli and S.
Typhimurium wild-type strains and mutants defective in the
uptake of glucose and/or glucose-6P. The results indicate strain-
specific differences in the intracellular metabolism of these human
pathogens and allow conclusions about the major carbon sources
and metabolic pathways used by these pathogens when replicating
in their specific host cell compartments.
Results
The analysed enterobacterial wild-type strains and
mutants impaired in uptake of glucose, mannose and/or
glucose 6-phosphate
For the study on the intracellular metabolism of enteroinvasive
Escherichia coli (EIEC) and Salmonella enterica Serovar Typhimurium,
we used two EIEC isolates, EIEC HN280 (in the following termed
EIEC-1) and EIEC 4608-58 (subsequently termed EIEC-2)
belonging to different groups [31], and the S. Typhimurium
strain 14028 (abbreviated Stm). Mutants of all three strains
impaired in the uptake of glucose (deletions in ptsG and manXYZ
- in the following termed glucose-uptake mutant) and/or glucose-
6P (deletion in uhpT - in the following termed glucose-6P uptake
mutant) were recently constructed [32]. In vitro and in vivo growth
of all strains was performed in RPMI medium. This medium
which contains all amino acids except alanine in concentrations
between 0.1 and 2 mM (Table S1) was supplemented with 10 mM
glucose, mannose or glucose-6P. Replication within Caco-2 cells of
the wild-type and mutant strains were determined as described
recently [32]. The data relevant for the present study are
summarized in the supplementary Table S2 (see also [32]). The
results indicated that in vitro growth of the corresponding mutants
of all three strains was strongly impaired in the presence of glucose
and glucose-6P, respectively but all mutants were still able to grow
in Caco-2 cells albeit with strain-specific reduced efficiencies
compared to the wild-type strains (see Table S2 and [32]). To
understand the intracellular carbon metabolism of these strains we
applied the 13C-isotopologue profiling technique which we had
already successfully used for studying the intracellular carbon
metabolism of Listeria monocytogenes in J774 macrophages [30].
Growth properties of the enterobacterial wild-type and
mutant strains in Caco-2 cells
Caco-2 cells were used as host cells and cultured in RPMI
medium supplemented with 10% foetal calf serum (FCS) and 10
mM glucose which is close to the average value of the intestinal
glucose concentration [33,34]. When these cells reached 80 to
90% confluency they were infected with the two EIEC and the Stm
wild-type strains as well as with the various mutants. At a
multiplicity of infection (MOI) of 20 bacteria per host cell about
26106 EIEC-1 wild-type bacteria were taken up by the 26107
Caco-2 cells used for each infection assay (internalization
efficiency, 0.1; Table 1). Even at a MOI of 100 bacteria per host
cell, the EIEC-2 wild-type strain was internalized by Caco-2 cells
about 5 times less efficiently than EIEC-1, but grew inside the host
cells with a similar rate as EIEC-1, i.e. after the 6.5 h infection
period (time of harvest), there were 26108 intracellular EIEC-1
bacteria but only 36107 EIEC-2 bacteria (Table 1). Stm was taken
up with similar efficiency as EIEC-1, but its intracellular doubling
time was at least three fold longer than that of the EIEC isolates
(Table 1 and Table S2). However, using a MOI of 100 bacteria
per host cell and 8.5 h infection period, there were also about
16108 intracellular Stm bacteria at the time of harvest (Table 1).
Intracellular Metabolism
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The replication rates of the glucose-6P uptake mutants of all
three pathogens were comparable to those of the corresponding
wild-type strains. The glucose/glucose-6P uptake mutants of
EIEC-1 and EIEC-2 replicated with about half of the rate of the
corresponding wild-type strains. The replication rate of the
glucose/glucose-6P uptake mutant of Stm was less reduced (about
20%) as compared to the Stm wild-type strain [32].
Glucose consumption by the host cells and the bacterial
strains during infection
For a concise interpretation of the 13C-labelling data (described
below), we determined the consumption of uniformly 14C-labelled
glucose by the three enterobacterial wild-type strains after their
intracellular replication for 6.5 h (EIEC-1 and EIEC-2) or 8.5 h
(Stm) in Caco-2 host cells (applying similar infection conditions as
described above using again an external glucose concentration of
10 mM). The results shown in Fig. 1 indicate: (i) The 26107 Caco-
2 cells (in a 175 cm2 culture flask) incorporated about 4 mmol, i.e.
about 2% of the 200 mmol external 14C-glucose (specific activity of
0.5 MBq/mmol) during the infection period. This suggests that we
are working in our infection assays with excess of external glucose
throughout the infection period. (ii) The amount of 14C-label
incorporated into the Caco-2 cells was similar with or without
infection by the three enterobacterial pathogens, suggesting that
these infections do not alter glucose uptake by the Caco-2 cells. (iii)
After the 6.5 h infection period, the intracellular 26108 EIEC-
1and 107 EIEC-2 bacteria incorporated 14C-label corresponding to
0.8 mmol and 0.3 mmol glucose, respectively. The 14C-label
incorporated into the 108 intracellular Stm during the 8.5 h
infection period corresponds to 0.1 mmol glucose. (iv) Related to
the numbers of intracellular bacteria present in the Caco-2 host
cells after these infection times the data suggest that the two EIEC
strains incorporate 14C-label which corresponds to a roughly equal
amount of glucose per bacterial cell while Stm incorporated 5–8
times less per bacterial cell. These calculated glucose consumption
data thus concur with the observed intracellular replication rates
of the three pathogens (Table S2).
13C-Isotopologue profiling procedure
The method applied in the following for the study of carbon
metabolism of the three pathogens uses as major 13C-labelled
carbon substrate uniformly labelled 13C-glucose ([U-13C6]glucose).
This carbon substrate is degraded in the central catabolic
pathways leading to specific distributions of the 13C-label in the
arising catabolic intermediates and subsequently in many anabolic
products originating from these intermediates (e.g. amino acids
which we used in our study). Although the biosyntheses of amino
acids follow highly conserved pathways, the catabolic intermedi-
ates acting as precursors for these biosyntheses may be produced
by different reactions (e.g. pyruvate can be generated by glycolysis,
the Entner-Doudoroff, the pentose-phosphate cycle from carbo-
hydrates or by catabolism of certain amino acids and other carbon
sources; likewise acetyl-CoA can be generated by oxidation of
lactate, pyruvate, fatty acids etc.). As a consequence, specific 13C-
isotopologue distributions (13C-isotopologue patterns or profiles)
are generated in amino acids reflecting the metabolic history of
their precursors. The 13C-profiles of the amino acids (and other
possible stable metabolites that may be used for 13C-profiling)
were routinely determined in our study by quantitative mass
spectrometry (MS). Although more direct information regarding
the 13C-distribution within 13C-labelled metabolites can be
obtained by NMR, MS showing a higher sensitivity - as little as
107 bacteria may be sufficient for MS-based 13C-isotopologue
profiling [30] - was applied here, since we had to deal with rather
low numbers of intracellular bacteria that could be isolated from
the infected host cells. Although 13C-isotopologue profiling is in
principle applicable to any labelled metabolite detectable by GC/
MS or LC/MS, this method is particularly well established for
amino acids [25,26,27,28,29]. After separation of host cells and
bacteria, total protein isolated from each partner is hydrolysed
under acidic conditions yielding free amino acids. Due to the
acidic conditions, Asn and Gln are converted into Asp and Glu,
respectively. The values reported below for Asp and Glu are
therefore always average values for Asn/Asp respectively Gln/
Glu. Moreover, Trp and Cys are destroyed by acidic hydrolysis.
Table 1. Infection conditions used in this study.
WT DuhpT
DptsG,
manXYZ
DptsG,
manXYZ,
uhpT
EIEC-1 MOI 20 20 75 75
cfu 1 h p.i. 1.96106 9.76105
cfu 6.5 h p.i. 2.36108 1.76108 2.06107 3.06107
EIEC-2 MOI 100 100
cfu 1 h p.i. 5.66105 5.66105
cfu 6.5 h p.i. 3.46107 1.36106 {
Stm MOI 100 100 100 100
cfu 1 h p.i. 3.16107 2.36107
cfu 8.5 h p.i. 1.16108 7.36107 4.06107 8.76107
The multiplicities of infection (MOI) used for this study to infect 26107 cells per
175 cm2 cell culture flask are shown in Table 1. Ten flasks were infected for each
strain and experiment. The number of intracellular bacteria per flask at the
beginning of the intracellular replication phase 1 h post infection (p.i.) and the
number of bacteria at harvest time (6.5 or 8.5 h p.i.) corresponds approximately
with the intracellular generation times shown in Table S2. More details on the
infection process and the determination of replication rates are given in [32].
{indicates beginning autolysis.
doi:10.1371/journal.pone.0010586.t001
Figure 1. Glucose consumption by the host cells and the
intracellular bacteria. Infection of Caco-2 cells with the three
enterobacterial wild-type strains was carried out as described in
Materials and Methods for 6 and 8 h, respectively, using 200 mmol of
14C-labelled glucose per 20 ml culture medium. The columns show the
amount of 14C-label (corresponding to the consumed 14C-glucose in
mmol) incorporated into the total host cells with or without bacterial
infection (hatched bars), into the separated host cells (light gray bars)
and into the isolated bacteria (dark grey bars).
doi:10.1371/journal.pone.0010586.g001
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After silylation of the amino acids and separation of these
derivatives by GC, the 13C-isotopologue composition is analysed
by MS showing the abundance of molecular species exceeding the
mass of the parent ion (M) by one or more mass units (M+1, M+2,
M+3, etc.). Arg as well as Met can hardly be detected in typical
GC/MS runs due to low signal to noise ratios (see also [21] for
discussion of the method). The analysis of the 13C-isotopologue
profiles in the 13C-labelled and hence de novo synthesised amino
acids from the bacteria and host cells allows the determination of
the 13C-incorporation rate (excess 13C) of the catabolic interme-
diate(s) derived from the supplied [U-13C6]glucose leading to the
formation of a given 13C-labelled amino acid. From these data, the
contribution of reactions and pathways leading to the formation of
the precursors for a specific amino acid were deduced.
Incorporation of 13C-label from external [U-13C6]glucose
into amino acids of the intracellularly growing EIEC and
Stm wild-type strains
For the determination of the intracellular carbon metabolism,
we used a similar 13C-isotopologue profiling protocol as reported
previously for L. monocytogenes [30]. In short, Caco-2 cells were
again infected with EIEC-1, EIEC-2 or Stm with MOI of 20 and
100 bacteria, respectively per Caco-2 cell as described above (see
also Table 1). The infected cells were incubated in RPMI medium
(containing 10 mM [U-13C6]glucose) for 6 h (in case of the two
EIEC strains) or 8 h (in case of Stm). At the time of harvest, there
were again approximately 108 EIEC-1 and Stm bacteria and 107
EIEC-2 bacteria in 26107 host cells applied in each infection
assay. Bacteria were separated from the host cells by differential
centrifugation.
In the EIEC-1 strain, all amino acids detectable by this method,
except Leu, acquired significant 13C-label from exogenous
[U-13C6]glucose. The
13C-incorporation rates varied, however,
considerably in the individual amino acids ranging from 1% excess
of 13C-label (in Ile) to 33% (in Ala). These data are shown by a colour-
code in Fig. 2A (lane a) and as numerical values in Table S3.
In the EIEC-2 strain only six amino acids (Ala, Asp, Glu,Val, Ser
and Gly) were 13C-labelled with incorporation rates ranging from 1%
excess 13C-label (in Gly) to 12% (in Ala) as shown in Fig. 2B, lane m
and Table S3.Notably, amino acids whose biosynthesis depends on
intermediates of the pentose phosphate cycle (i.e. Tyr, Phe and His -
requiring erythrose 4-phosphate and phosphoribosyl pyrophosphate,
respectively), but also Lys and Thr, remained practically unlabelled.
Thus, the de novo synthesis of amino acids (as typical anabolic
monomers) appears to be considerably higher in EIEC-1 than in
EIEC-2 when replicating in Caco-2 cells.
Stm growing in the SCV of Caco-2 cells exhibits still another
pattern of 13C-labelled amino acids. More specifically, 10 amino
acids acquired excess 13C-label from [U-13C6]glucose with
13C
excess rates ranging from 2% (in Phe and His) to 21% (in Ala)
(Fig. 2C, lane q, Table S3). The rather high 13C-enrichment values
of the amino acids in the SCV-residing Stm indicate that active de
novo synthesis of amino acids occurs in the intracellular Stm
bacteria. Hence, transport of [U-13C6]glucose or derivative(s) of it
generated by the host cell into the SCV must be quite efficient.
The nature of the 13C-labelled carbon source(s) provided by the
host cells to these intracellular bacteria is analysed in the following
section using the glucose and/or glucose-6P uptake mutants.
13C-Incorporation into amino acids of EIEC and Stm
glucose and/or glucose-6P uptake mutants
To determine whether the 13C-label in amino acids of the three
enterobacterial strains originates directly from [U-13C6]glucose or
catabolic intermediates produced from [U-13C6]glucose (and
hence also 13C-labelled) by the host and subsequently transferred
to the bacteria, we performed labelling experiments with mutants
that are impaired in the transport of glucose, glucose-6P or both,
following the same experimental settings used before for the
corresponding parental strains. As described above, all glucose-
and glucose/glucose-6P- uptake mutants are still able to replicate,
albeit at reduced rates, in Caco-2 cells [32]. This already suggests
that the mutants can use - in the absence of glucose - (an)
alternative carbon substrate(s).
The 13C-enrichment in the amino acids from the EIEC-1
glucose/glucose-6P uptake mutant was strongly reduced com-
pared to that in the corresponding amino acids from the parental
strain (reduction by 50% in Glu to 95% in Thr). Notably, only
three amino acids acquired excess 13C-label above 1% (Ala
.Glu.Asp) (Fig. 2A, lane b and Table S3). This result confirms
that a large portion (. 50%) of de novo synthesised amino acids
directly derived from [U-13C6]glucose (or [U-
13C6]glucose-6P) in
the parental strain.
To distinguish whether glucose and/or glucose-6P function as
major carbon nutrients for intracellular EIEC-1, the glucose-6P-
and the glucose-uptake mutants of this EIEC strain were
compared. Whereas the 13C-incorporation rates into amino acids
were similar for the parent strain and the glucose-6P uptake
mutant (Fig. 2A, lanes a and d), the values for amino acids from
the glucose uptake mutant were reduced to a similar extent as in
the glucose/glucose-6P uptake mutant (Fig. 2A, lanes b and c).
This provides clear evidence that glucose, but not glucose-6P, is
the preferential carbon source for the intracellular metabolism of
EIEC-1 under the applied conditions.
In contrast to the glucose/glucose-6P uptake mutant of EIEC-1
the corresponding mutant of EIEC-2 exhibited less reduction in
13C-incorporation into the de novo synthesised amino acids (Fig. 2B,
lanes m and n; Table S3) suggesting that glucose (or glucose-6P) is
less efficiently utilised in this strain as carbon source for the
intracellular metabolism than in EIEC-1 and alternative carbon
source(s) may be consumed in addition to glucose. As indicated by
the more detailed analyses of the isotopologue distribution in
amino acids (see below), C3-compounds are potential nutrients
under these conditions.
The glucose/glucose-6P uptake mutant of Stm showed a strongly
reduced 13C-incorporation (by .50%) into the (fewer) de novo
synthesised amino acids as compared to the wild-type strain
(Fig. 2C, lanes q and r; Table S3). The glucose-6P uptake mutant
incorporated 13C-label into all amino acids as efficiently as the
wild-type strain, while the glucose uptake mutant incorporated
13C-label with the same low efficiency as the glucose/glucose-6P
uptake mutant (Fig. 2C, lanes s and t). This shows that glucose, but
not glucose-6P, is a major carbon source for Stm when replicating
in the SCV of Caco-2 cells.
Faster proliferating Caco-2 cells show higher
13C-incorporation into amino acids of the host cells and
the bacterial wild-type strains but not of the glucose/
glucose-6P uptake mutants
In faster proliferating Caco-2 cells (obtained by using a less
dense monolayer of Caco-2 cells, i.e. about 60% confluency
instead of about 90% used in the previous experiments), the 13C-
incorporation into the de novo synthesised amino acids of the Caco-
2 cells and the intracellularly replicating EIEC-1 and Stm wild-type
strains (EIEC-2 was not tested) was significantly enhanced.
However, this increased 13C-incorporation was not observed in
the glucose/glucose-6P uptake mutants of these strains (Fig. 2A
Intracellular Metabolism
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and C, lanes e, f and u, v). The reason for the higher 13C-
incorporation is apparently an enhanced glucose uptake by these
Caco-2 cells, also resulting in enhanced [U-13C6]glucose uptake by
the bacteria. Subsequently, this leads to higher 13C-incorporation
into amino acids of the host cells (Fig. 2A, lanes k compared to l
and a compared to b) and the wild-type bacterial strains (compare
Figure 2. 13C-Incorporation into amino acids of the intracellular bacteria and the infected Caco-2 host cells (see also Table S3). The
colours (according to a quasi logarithmic scale) indicate the amount of 13C-incorporation in each amino acid. (A) EIEC-1 wild-type strain, the indicated
mutants of this strain (lanes a-f), and the corresponding Caco-2 cells (g-l). Colours in (a-d)/(g-j) and (e,f)/(k,l) show 13C-incorporation into amino acids
of slow and faster proliferating Caco-2 cells, respectively. (B) EIEC-2, isogenic glucose/glucose-6P uptake mutant (m-n), and the Caco-2 cells infected
with these two strains (o-p). (C) Stm and the indicated mutants; (q-b) show the 13C-incorporation into amino acids of the bacterial strains and the
infected Caco-2 cells in the same order as in (A). The small white stars mark values with high standard deviations (see also Tables S3 and S4). White
boxes indicate amino acids that could not be detected.
doi:10.1371/journal.pone.0010586.g002
Intracellular Metabolism
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Fig. 2A, lanes a compared to e and q compared to u), but not of
the glucose/glucose-6P uptake mutants (compare Fig. 2A, lanes b
compared to f and r compared to v). This observation further
supports the assumption that glucose is the preferential carbon
source for the intracellularly replicating EIEC-1 and Stm wild-type
strains, but not of the glucose/glucose-6P uptake mutants.
Comparison of the 13C-isotopologue patterns of the
amino acids in the wild-type strains and the glucose/
glucose-6P uptake mutants of the three pathogens
The comparison of the 13C-incorporation rates between the
wild-type strains and the glucose/glucose-6P uptake mutants
already allows conclusions about the nature of the preferred
carbon sources as described in the previous section. However,
more specific insights into the intracellular metabolism can be
obtained from the isotopologue distributions in each of the 13C-
labelled amino acids.
To better follow our conclusions, the reader is also referred to
Figs. S1 and S2 showing the major catabolic pathways and
anapleurotic reactions operating in all three pathogens and the
expected as well as the observed 13C-isotopologues when
[U-13C6]glucose or its derivatives are channelled through these
pathways.
Amino acids derived from glycolytic intermediates (Ala,
Val, Ser, Gly)
(a) in the wild-type strains. Ala, although de novo
synthesised to a different extent in EIEC-1, EIEC-2 and Stm
(Fig. 2 and Fig. 3A-E, black bars, scale at the left side), is
characterised by the triple 13C-labelled isotopologue at high
abundance in all three strains. The relative fractions of this
isotopologue (M+3) are indicated by red bars in Fig. 3A-E; scale at
right; for numerical values, see Table S4). The metabolic
precursor for this 13C3-Ala isotopologue is
13C3-pyruvate which
may derive in the bacteria either directly from [U-13C6]glucose by
glycolysis, the Entner-Doudoroff pathway, the pentose phosphate
cycle (via 13C3-glyceraldehyde phosphate) or a combination of
these pathways. Alternatively, it can derive from 13C3-substrates
(e.g. glycerol, glycerol 3-phosphate, lactate, or pyruvate) generated
in the host cells from [U-13C6]glucose and subsequently imported
(as 13C3-substrate) into the bacteria and then metabolised to
13C3-
pyruvate/Ala. However, a major participation of host cell-derived
13C-labelled carbon substrates which predominantly would lead to
13C2-labelled acetyl-CoA (e.g. from host cell derived fatty acids,
several amino acids and to some extent also lactate and pyruvate)
can be excluded as source for bacterial pyruvate, since in this case
13C2- and
13C1-isotopologues of pyruvate (and hence Ala) should
have mainly been generated via the glyoxylate shunt and PEP
carboxykinase. The minor amounts of 13C1- and
13C2-Ala
observed in all three strains (about 5–8% of the labelled Ala)
may indeed be produced by these latter reactions (see below). A
major contribution of 13CO2 (generated by decarboxylation of
[U-13C6]glucose or its intermediates (e.g. pyruvate)) in the
formation of 13C1-labelled components can be excluded since no
13C1-labelled Asp was detected which should derive from of
13C1-
oxaloacetate generated by PEP carboxylation with 13CO2.
The 13C-isotopologue pattern of Val (produced by two pyruvate
molecules with removal of one carbon atom by decarboxylation)
mainly showed the 13C5-isotopologue (purple coloured bar in
Fig. 3) which can be explained by the assembly of two 13C3-
labelled pyruvate molecules. There was also a substantial amount
of 13C2- and
13C3-Val which probably derives from one unlabelled
and one 13C3-labelled pyruvate molecule. The other two branched
chain amino acids, Ile and Leu, were not (or in case of EIEC-1
only weakly) 13C-labelled, suggesting that these amino acids are
either not synthesised de novo but rather imported from the host
cells.
The biosyntheses of Ser and Gly are closely linked. Ser is mainly
generated from 3-phosphoglycerate (Fig. S1), while Gly derives
from Ser by removal of one C-atom by Ser-hydroxymethyltrans-
ferase with the participation of tetrahydrofolate which is thereby
converted to N5, N10-methylenetetrahydrofolate. However, the
generation of Ser from Gly by this reaction is less likely in these
pathogens under the applied conditions. In all strains, 13C3-Ser
was the major isotopologue (red bar in Fig. 3), but 13C1- and
13C2-
Ser (blue and yellow bars, respectively) were also observed in
substantial (but different) amounts (Fig. 3A-E). As mentioned
before, 13C3-Ser is apparently produced directly from
13C3-
labelled 3-phosphoglycerate, the latter being generated from
[U-13C6]glucose via the glycolytic pathway (Fig. S1). In contrast,
13C1- and
13C2-Ser isotopologues can not be produced by this
route but must originate from the corresponding 13C-labelled PEP
isotopologues which may be produced from 13C2-oxaloacetate by
PEP carboxykinase (see Fig. S2). Since PEP-carboxykinase is
induced only at low glucose concentration [35,36], these data
suggest that the amount of [U-13C6]glucose in the Caco-2 cells
which becomes available to the intracellular bacteria must be quite
low which is also evident from the data shown in Fig. 1. The
observed 13C-isotopologues of Gly (mainly 13C2- and less
13C1-
Gly; Fig. 3A-E) can be explained by their synthesis from the
respective 13C-Ser isotopologues catalysed by Ser-hydroxymethyl-
transferase.
Amino acids derived from glycolytic intermediates (Ala,
Val, Ser, Gly)
(b) glucose/glucose-6P uptake mutants. In the EIEC-1
mutant, 13C3-Ala remained the predominant
13C-isotopologue
similar as in the wild-type strain (Fig. 3A and B) suggesting that
this mutant – in the absence of 13C-glucose – must have access to
13C-labelled substrate(s) which again mainly yield(s) 13C3-pyruvate.
The 13C3-isotopologue of Ser in this mutant was much more
reduced than the 13C1- and
13C2-isotopologues indicating that in
the absence of glucose the residual de novo synthesis of Ser now
originates more from 13C1- and
13C2-labelled 3-phosphoglycerate
generated from 13C1- and
13C2-PEP (produced from oxaloacetate
by PEP carboxykinase) (Fig. S2). The Gly isotopologues can again
be explained by their generation from the Ser-isotopologues by
elimination of the C1-unit. De novo synthesis of Val does not seem
to occur in this mutant as no 13C-labelled Val was observed.
In the EIEC-2 mutant, 13C3-incorporation into Ala, Ser and Gly
was less reduced (only by about 50% compared to the wild-type
strain) than in the EIEC-1 mutant (black bars in Fig. 3C). De novo
synthesis of Val, already low in the wild-type strain, reached
background level in the mutant. Interestingly, the 13C-isotopolo-
gue patterns of Ala, but also of Ser and Gly, were similar to those
of the wild-type strain (Fig. 3C), suggesting that 3-phosphoglyc-
erate serving as precursor of the latter amino acids was generated
in the mutant similarly as in the wild-type strain even in the
absence of glucose. This confirms that this strain may use, in
addition to glucose, a C3-substrate, such as glycerol.
In the Stm mutant, there were again remarkable differences
between the 13C-isotopologues patterns observed with the mutant
and the wild-type strain, respectively (Fig. 3D and E and Table
S4). In Ala, the level of the major 13C3-isotopologue decreased by
about 50% in the mutant, but the levels of the minor 13C1- and
13C2-isotopologues remained unchanged or were even higher in
the mutant. Likewise, the 13C3-isotopologue of Ser was stronger
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reduced (.3 fold) than the 13C1- and
13C2-isotopologues (,1.5
fold), again suggesting its generation from 13C1- and
13C2-labelled
3-phosphoglycerate, as already discussed above for EIEC-1.
Interestingly, 13C-labelled Val was observed in the Stm mutant,
but the 13C5-isotopologue of Val, predominant in the wild-type
strain was again more reduced (.5 fold) than the 13C1-,
13C2-,
13C3-, and
13C4-isotopologues (about 1.5 fold) again suggesting the
involvement of 13C1- and
13C2-labelled pyruvate (and hence the
generation of the corresponding PEP isotopologues by gluconeo-
genesis) for their production (together with unlabelled pyruvate).
Amino acids derived from intermediates of the TCA cycle
(Glu, Asp, Pro, Thr, Lys)
(a) in the wild-type strains. Although the 13C-
incorporation into Glu (and hence the amount of de novo
Figure 3. 13C-Isotopologue distribution in the amino acids de novo synthesised in intracellular EIEC-1 (A), EIEC-2 (C) and Stm (D)
replicating in slower proliferating Caco-2 cells as well as EIEC-1 (B) and Stm (E) replicating in faster proliferating Caco-2 cells (see
text for details); Caco-2 cells infected with EIEC-1 (F) (coloured bars, see also Table S4). The 13C-distribution of the glucose-6P uptake
mutants is similar to wt and that of the glucose uptake mutant similar to the glucose/glucose-6P uptake mutants (D) and therefore not shown (but
see Table S4).The coloured boxes indicate the percentage of the 13C-isotopologues (M+1 to M+9) of the different amino acids (right scales). The black
bars indicate the overall amount of 13C-incorporation (in mol%) into amino acids of the wild-type strains (wt) and their corresponding glucose/
glucose-6P uptake mutants (D) as well as in the Caco-2 cells, infected with wt and D strains (left scales). Note that two left scales were used in A-F to
better differentiate the 13C-incorporation into the various de novo synthesised amino acids of the three intracellular bacteria and their mutants. *
indicates that data from glucose uptake mutant are displayed. ** These data are not shown in the figure due to high standard deviations or missing
data points (see Table S4).
doi:10.1371/journal.pone.0010586.g003
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synthesised Glu) considerably differed among the three
enterobacterial wild-type strains (Fig. 3A-E, black bars), 13C2-
Glu (yellow bars) was the predominant isotopologue in all three
strains followed by 13C4-Glu (green bars).
13C2-labelled a-
ketoglutarate as precursor of 13C2-Glu is apparently generated in
the TCA cycle from 13C2-acetyl-CoA and unlabelled oxaloacetate.
13C4-a-ketoglutarate as precursor of the
13C4-Glu isotopologue
may be produced by a second round of the TCA cycle from 13C2-
oxaloacetate and 13C2-acetyl-CoA. However, in this case an equal
amount of 13C3-labelled a-ketoglutarate and hence
13C3-Glu
should also have been generated which apparently is not the case.
Therefore, a major portion of 13C4-a-ketoglutarate as precursor of
13C4-Glu must have been generated in the TCA cycle from a
13C3-oxaloacetate isotopologue and
13C2-acetyl-CoA (Fig. S1).
Indeed, the major 13C-Asp isotopologue was found to be 13C3-Asp
(red bars in Fig. 3A-E; Asp directly derives from oxaloacetate) in
all three enterobacteria, followed by the 13C2-Asp isotopologue
(yellow bars). The latter Asp isotopologue most likely derives from
13C2-oxaloacetate generated again in the TCA cycle from
13C2-
acetyl-CoA and unlabelled oxaloacetate. 13C3-Oxaloacetate as
precursor for the 13C3-Asp isotopologue could in principle be
generated by a second round of the TCA cycle from 13C2-
oxaloacetate and 13C2-acetyl-CoA. However, the higher amount
of 13C3-Asp compared to
13C2-Asp (which should be produced in
equal amounts in the TCA cycle) favours the predominant
formation of 13C3-Asp from
13C3-oxaloacetate generated via
carboxylation of 13C3-labelled PEP by PEP carboxylase (Fig. S1;
there is no pyruvate carboxylase in E. coli and S. Typhimurium).
The apparent formation of 13C3-labelled PEP can be explained by
conversion of [U-13C6]glucose by glycolysis (and/or the Entner-
Doudoroff pathway via 13C3-glyceraldehyde phosphate).
However, also 13C3-labelled glycerol or glycerol-3P could serve
as precursors, but not carbon substrates mainly yielding 13C2-
acetyl-CoA, like 13C-labelled fatty acids. 13C3-Labelled pyruvate
and lactate as major carbon substrates are also less likely for the
same reason (see also discussion above for Ala).
Pro was 13C-labelled in appreciable amounts only in EIEC-1
and Stm (Fig. 3A-E, black bars). As expected, the 13C-isotopologue
patterns of Pro were similar to those in Glu which is the direct
precursor of Pro (coloured bars in Fig. 3A-E).
Asp is the precursor of Thr and Lys. These two amino acids
were again 13C-labelled and hence de novo synthesised in significant
and well reproducible amounts in EIEC-1 and Stm but not in
EIEC-2 (Fig. 3A-E, black bars). Since the carbon backbone of Thr
is identical to that of Asp, the isotopologue pattern of Thr is
expected to be identical to that of Asp which was indeed the case
in both strains (Fig. 3A-E, coloured bars). The biosynthesis of Lys
follows (as in most bacteria) the diaminopimelic acid pathway and
requires, in addition to Asp, pyruvate with the concomitant loss of
one C-atom from the latter precursor by decarboxylation. The
occurrence of 13C3- and
13C5-Lys as main isotopologues is
therefore in accord with their generation from 13C3-Asp (the
major 13C-Asp isotopologue) and unlabelled or 13C3-labelled
pyruvate, respectively (in the latter case with the loss of 13CO2).
The minor 13C2-Lys isotopologue may be the product of
13C2-Asp
and unlabelled pyruvate or unlabelled Asp and 13C3-labelled
pyruvate, respectively.
Amino acids derived from intermediates of the TCA cycle
(Glu, Asp, Pro, Thr, Lys)
(b) in the glucose/glucose-6P uptake mutants. In the
EIEC-1 mutant, 13C-incorporation into Glu, Asp, Pro, Thr, and
Lys was highly reduced as compared to the wild-type strain
(Fig. 3A and B, black bars). The 13C-isotopologue patterns of Asp
and Glu (similar amounts of 13C2- and
13C3-Asp, equal amounts of
13C3- and
13C4-Glu isotopologues and high amounts of
13C2-Glu)
suggest that the corresponding oxaloacetate and a-ketoglutarate
precursors are mainly derived via two rounds of the TCA cycle,
fed by 13C2-acetyl-CoA (Fig. S2). Apparently, PEP carboxylation
did not yield oxaloacetate at the same high rates as detected for the
wild-type strain.
In the EIEC-2 mutant, the already lower 13C-incorporation into
Glu and Asp (compared to EIEC-1) was only about 2-fold reduced
compared to the wild-type (Fig. 3C, black bars). The 13C-
isotopologue patterns of these two amino acids were similar to
those of the EIEC-1 mutant, suggesting a similar generation of Glu
and Asp in the EIEC-2 mutant, i.e. by channelling 13C2-acetyl-
CoA through up to two rounds of the TCA cycle. There was an
equally strong reduction of the 13C3-isotopologue of Asp in this
mutant (compared to the wild-type strain) as in the corresponding
EIEC-1 mutant, suggesting that generation of oxaloacetate by PEP
carboxylation does also not occur in the EIEC-2 mutant.
In the Stm mutant, 13C-incorporation into Glu, Pro and Asp was
less than 50% reduced, while 13C-incorporation into Thr and Lys
was more than 70% lower than in the wild-type strain (Fig. 3D and
E, black bars). The 13C-isotopologue patterns of Glu and Asp
(equal amounts of 13C2- and
13C3-Asp, equal amounts of
13C3-
and 13C4-Glu) resembled those of the two EIEC strains and suggest
that the corresponding 13C3-labelled oxaloacetate and a-ketoglu-
tarate precursors were again generated by channelling 13C2-acetyl-
CoA through two rounds of the TCA cycle (Fig. S2). The major
13C-isotopologue of the weakly labelled Lys was 13C3-Lys, in
contrast to the wild-type strain where more 13C5- than
13C3-Lys
isotopologue was generated (see above). The preferential gener-
ation of the 13C3-Lys isotopologue might involve
13C2- and
13C3-
Asp as precursors.
Amino acids requiring intermediates of the pentose-
phosphate cycle (His, Phe, Tyr)
(a) in the wild-type strains. 13C-labelled His was produced
in EIEC-1 and Stm in low (in EIEC-2 very low), but reproducible
amounts (Fig. 3A-D, black bars; note that the scale for His, Gly,
Thr, Phe, and Tyr differs from that for Ala, Asp, Glu, Ser, Val,
and Lys). His biosynthesis requires phosphoribosyl pyrophosphate
(PRPP) produced in the pentose phosphate cycle, and ATP which
contributes one C-atom and the two N-atoms to the imidazol ring
of His. In all strains, the major His isotopologue was 13C5-His
(purple bar in Fig. 3A-D) which may be generated from unlabelled
ATP and 13C5-labelled PRPP. The occurrence of
13C5-PRPP
requires its direct synthesis from [U-13C6]glucose by the pentose
phosphate cycle, again reflecting the use of glucose as major
carbon source in all three strains (Fig. S1). The minor 13C-His
isotopologues, which were different in the three strains, are also of
interest: the occurrence of 13C6-His (orange bar) in EIEC-1 and
Stm indicates that one additional 13C-atom derives from 13C-
labelled ATP. This provides evidence for de novo biosynthesis of
purines in these two intracellular enterobacteria (more in Stm than
in EIEC-1; see Fig. 3A, B compared to D). In EIEC-2, there is an
additional 13C2-His isotopologue (yellow bar). The
13C2-label can
derive from 13C2-labelled PRPP suggesting that in EIEC-2 part of
PRPP does not directly come from [U-13C6]glucose but rather
from glucose produced by gluconeogenesis from a C3-substrate.
The almost equal amounts of 13C5- and
13C2-His in EIEC-2 may
therefore be taken as further evidence that this strain uses, in
addition to glucose, a C3-substrate (most likely glycerol – see Ser),
but not glucose-6P for its intracellular metabolism.
Phe and Tyr require for their biosynthesis two molecules of PEP
and one molecule of erythrose-4P, the latter representing a
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product of the pentose phosphate cycle. Both aromatic amino
acids were 13C-labelled in EIEC-1 at low, but reproducible
amounts (Fig. 3A and B, black bars). In Stm, Phe (but not Tyr) was
13C-labelled at a similar rate as in EIEC-1 (Fig. 3D). The major
isotopologues were 13C9-species in both strains (blue bars),
suggesting their generation from two molecules of 13C3-PEP and
one molecule of 13C4-erythrose-4P (with the loss of one
13C-atom
of PEP by decarboxylation). 13C4-Erythrose-4P can again only
derive directly from [U-13C6]glucose by the action of a
transketolase in the pentose phosphate pathway. In EIEC-2, 13C-
labelled Tyr and Phe were not reproducibly observed.
Amino acids requiring intermediates of the pentose-
phosphate cycle (His, Phe, Tyr)
(b) glucose/glucose-6P uptake mutants. A significant 13C-
incorporation into Phe, Tyr and His did not occur in any of the
three mutants, suggesting either the failure of de novo synthesis of
these amino acids in the absence of glucose, or a lack of 13C-
labelled intermediates of the pentose phosphate cycle due to
production of glucose by gluconeogenesis from unlabelled or only
weakly 13C-labelled carbon substrates utilised in the absence of
[U-13C6]glucose uptake.
Amino acids taken up by the intracellular pathogens
from the host cells
The largest portion of each amino acid isolated from the
bacteria after infection is unlabelled (Table S4) indicating that the
major part of each amino acid is either synthesised from unlabelled
carbon substrate(s) or imported from the host cell. Unlabelled host
cell amino acids could be either taken up by the host cell from the
culture medium or generated by proteolytic degradation of
unlabelled host cell proteins. To answer the question whether
amino acids from the host cell are equally accessible to cytosolic
and phagosomal bacteria, the Caco-2 cells were 13C-prelabelled
prior to infection (by growing Caco-2 cells in RPMI medium
supplemented with 10% FCS and 10 mM [U-13C6]glucose for ten
generations). The 13C-labelled host cells were then infected (in the
presence of 10 mM unlabelled glucose) with the two EIEC and the
Stm wild-type strains as well as the glucose/glucose-6P uptake
mutants for 6.5 or 8.5 h. We found in all three intracellular
pathogens only those amino acids 13C-labelled (Ala, Glu, Asp, Ser,
Gly, and Pro) which were also 13C-enriched in the host cells
(Fig. 4B). Moreover, the 13C-isotopologue profiles of the bacterial
amino acids were identical with those from the host cells (Table
S4). This suggests that these amino acids are taken up and directly
incorporated into bacterial protein without any significant
catabolic turnover by the bacterial metabolism. However, their
amounts showed significant, strain-specific differences. Amino acid
uptake was lowest by the EIEC-1 wild-type strain and highest by
the EIEC-2 strain (Fig. 4B, lanes c and e; Table S5). The amino
acid uptake rate of the glucose/glucose-6P uptake mutant of
EIEC-1 was considerably higher (by up to 50%, depending on the
amino acid) than that of the corresponding wild-type strain (lanes c
and d, Table S5), while the glucose/glucose-6P uptake mutant of
EIEC-2 was even slightly lower (by about 10%) than that of the
wild-type strain (lanes e and f, Table S5). The amount of labelled
amino acids taken up by Stm (lane g) was in between that of the
two EIEC strains while the Stm glucose/glucose-6P uptake mutant
showed again a slight but reproducible increase (about 13%) in the
uptake of host cell-derived amino acids compared to the wild-type
strain (lanes g and h). In summary, these data show (i) that
cytosolic as well as phagosomal bacteria have access to host cell
amino acids and (ii) that the amount of host cell-derived amino
acids taken up by the three intracellular enterobacterial strains is
reverse to the amount of amino acids de novo synthesised by these
bacteria.
Is the metabolism of Caco-2 host cells affected by the
infection of the intracellular pathogens?
To determine the effect of the infection by the studied
intracellular pathogens on the carbon metabolism of the host
cells, we compared the 13C-incorporation into the de novo
synthesised amino acids of the uninfected and infected Caco-2
host cells. Both, uninfected Caco-2 cells as well as Caco-2 cells
infected by the three strains, incorporated 13C-label deriving from
[U-13C6]glucose into six non-essential amino acids with similar
rates. Excess 13C-label was about: for Ala 11%, for Glu 3%, for
Asp 2%, for Ser 3%, for Gly 2%, and for Pro 1%, as shown for the
EIEC-2 strain in Fig. 4A and Table S5. Among these amino acids,
Ala, Glu, Asp and Ser derive from intermediates of glycolysis or
the TCA cycle, while Gly and Pro are products of Ser and Glu,
respectively. The large amount of de novo synthesised Ala is
probably due to the absence of this amino acid in the used RPMI
culture medium which contains all other amino acids in
concentrations of about 0.1 to 2 mM (see also Table S1). The
fact that the 13C-excess values of uninfected and infected Caco-2
cells are virtually identical (Fig. 4A, lanes a and b) suggests that the
infection by the three pathogens does not significantly affect the
glucose uptake and metabolite fluxes along glycolysis and the TCA
cycle of the host cells.
Not only the rate of 13C-incorporation, but also the 13C-
isotopologue patterns of these amino acids remained essentially
unaltered by the infections (Fig. 3F; Table S4). Note that these
patterns were quite different from those of the corresponding
amino acids of the pathogens indicating that the procedure applied
for the separation of host cells and bacteria worked well. The 13C-
Figure 4. 13C-Incorporation into amino acids of host cells
(Caco-2) and intracellular bacteria (see also Table S5). (A) 13C-
labelled amino acids in Caco-2 cells (not infected) grown in the
presence of 10 mM [U-13C6]glucose for 6h (lane a) and with infection by
EIEC-2 (infection by EIEC-1 led to similar results) (lane b). (B) 13C-labelled
amino acids in Caco-2 cells and bacteria when the Caco-2 cells were
grown for 10 generations in the presence of 10 mM [U-13C6]glucose
and then infected with the bacteria. The data shows the uptake of the 6
labelled host cell amino acids by the three intracellular bacterial wild-
type strains (wt) and the corresponding glucose/glucose-6P uptake
mutants (indicated as D) during the 6.5 or 8.5 h period of infection
(lanes c-h). Labelled amino acids of the Caco-2 host cells 6.5 or 8.5 h
after infection by the wild-type strains (wt) or their glucose/glucose-6P
uptake mutants (D) (lanes i-n). Colours indicate the amount of 13C-
incorporation (% 13C) according to a quasi logarithmic scale.
doi:10.1371/journal.pone.0010586.g004
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isotopologue patterns of the amino acids in part de novo synthesised
by the host cells are in agreement with the assumption that glucose
is catabolised mainly via glycolysis and the TCA cycle as indicated
by the main 13C-isotopologues of Ala (13C3-Ala), Asp (
13C2-Asp)
and Glu (13C2-Glu). The occurrence of the
13C3-Asp isotopologue
and of the 13C3- and
13C4-Glu isotopologues at equal amounts
(especially observed in the faster proliferating Caco-2 cells)
suggests that the host cell TCA cycle undergoes up to two rounds
during the infection.
Discussion
We have analysed by 13C-isotopologue profiling the intracellu-
lar carbon metabolism of enteroinvasive E. coli (EIEC; closely
resembling Shigella species), and S. enterica Serovar Typhimurium
(S. Typhimurium). These two intracellular enterobacterial path-
ogens replicate in two different compartments of the infected cells,
namely the cytosol and the Salmonella-containing-vacuole (SCV),
respectively. Hence, they may differently interfere with the
metabolism of the host cells.
Under the applied culture conditions, all three enterobacterial
strains under study take up glucose (but not glucose-6P) directly
from the host cell (however with strain-specific efficiencies) and
catabolise it mainly through glycolysis and/or the Entner-
Doudoroff pathway followed by the TCA cycle (Fig. 5A and Fig.
S1). This conclusion is based on the observation that the bacterial
mutants impaired in glucose uptake show strong (strain-depen-
dent) reduction of 13C-incorporation into amino acids, while all
mutants impaired in glucose-6P transport exhibit the same 13C-
incorporation into all amino acids as the corresponding wild-type
strains when growing within Caco-2 cells. Glucose uptake mutants
of the three pathogens under study were generated by deleting the
ptsG and manXYZ operons encoding the major PTS glucose
permeases of E. coli and S. Typhimurium [37,38,39]. One has to
consider, however that the PtsG permease is able to also transport
other carbohydrates, such as glucosamine, N-acetylglucosamine,
fructose, and a-glucosides, albeit at much lower efficiency than
glucose [7,39]. In principle, these latter carbohydrates could be
generated from [U-13C6]glucose by the host cells, but due to their
presumably low cellular concentrations it is very unlikely that a
significant portion of the 13C-incorporation into the bacterial
amino acids derives from these carbohydrates. The major
substrate for ManXYZ is mannose. Hence, the uptake of host
cell-derived 13C-mannose cannot be strictly excluded, but is also
unlikely since the DmanXYZ mutant (strongly impaired in mannose
transport) shows the same 13C-incorporation into the amino acids
as the wild-type strain (data not shown).
Uptake of glucose-6P was abolished in all three enterobacterial
pathogens by the deletion of uhpT. However, the UhpT permease
can not only accept 13C-glucose-6P as substrate, but also other
13C-labelled phosphorylated sugars, such as glucose-1P, mannose-
6P, fructose-6P and ribose-5P [40,41] which may also be formed
from [U-13C6]glucose in the host cells. Since the uhpT mutants of
all three strains show similar rates of 13C-incorporation into the
amino acids as the corresponding wild-type strains, not only
glucose-6P but also these additional phosphorylated carbohydrates
can be excluded as major carbon substrates for the three
enterobacterial strains studied.
The cytosolically replicating EIEC strains have direct access to
[U-13C6]glucose that is transported from the external culture
medium into the cytosol of the Caco-2 cells by the sodium-
dependent D-glucose co-transporter SGLT1 residing in endo-
somes and by the apical GLUT2, a transporter allowing facilitated
diffusion of external D-glucose into the cytosol [33]. Although
glucose can be efficiently taken up by Caco-2 cells as by all cancer
cells (see also below), the cellular pool of free glucose is probably
low (see also Fig. 1) since glucose is quickly converted to glucose-6P
and channelled into the glycolytic pathway and the pentose
phosphate cycle [42,43]. High-affinity glucose transporters may
therefore be required by the intracellular bacteria to take up
sufficient amounts of glucose for feeding their intracellular carbon
metabolism. Differences in the affinity of the major glucose
transporters (e.g. PtsG) could therefore be the reason for the
Figure 5. Proposed catabolic pathways and metabolite fluxes
employed by the enterobacterial strains replicating in Caco-2
cells. Amino acids (in part) de novo synthesised by the bacteria are
encircled in green. The import of 13C-labelled amino acids from the host
cell is indicated by arrows, the magnitude of which roughly reflects the
relative amount of imported amino acids under the conditions (A) and
(B). EIEC-1 wild-type strain and Stm follow the metabolic pathways
shown in A (red arrows) which is mainly fed by glucose (indicated in
yellow), while the glucose/glucose-6P uptake mutants essentially follow
the metabolic pathways shown in B (red arrows) mainly fed by C3-
substrates. EIEC-2 appears to combine the pathways of model A and B.
doi:10.1371/journal.pone.0010586.g005
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observed striking difference in the efficiency by which the two
EIEC strains utilise glucose although they grow in the same
cytosolic environment (cf. models A and B in Fig. 5 and Figs. S1
and S2). The relatively low glucose affinity of the major glucose-
transporting PTS in Listeria monocytogenes (compared to that of E. coli
PtsG; A. Go¨tz, unpublished) may also explain why L. monocytogenes
uses glycerol rather than glucose as a major carbon substrate for its
intracellular carbon metabolism when replicating in the cytosol of
macrophages [30].
On the basis of our data, gluconate can be ruled out as major
carbon substrate for all three enterobacterial strains under the
applied conditions, since 13C-labelled gluconate formed by the
host cells from [U-13C6]glucose could still be taken up by the
DptsG, manXYZ mutants since the gluconate transporter (GntT)
remains fully functional in these mutants. If 13C-gluconate acts as a
major carbon source, the 13C-isotopologue patterns of the de novo
synthesised amino acids should therefore be similar in these
mutants as in the wild-type strains which definitely is not the case.
This conclusion differs form an earlier suggestion that gluconate
may be a preferred carbon source for intracellular S. Typhimur-
ium. This suggestion is based on the up-regulation of gntT
observed by transcript profiling of intracellularly grown S.
Typhimurium [44]. The gntT gene similar as the uhpT gene is
under glucose catabolite repression control [45] and the up-
regulation of these genes by intracellular S. Typhimurium
probably reflects the lower glucose concentration in the host cells
compared to the in vitro culture media used for growing S.
Typhimurium from which the reference RNA was isolated. This
may also explain the observed down-regulation of the glycolysis
and TCA genes in intracellularly grown S. Typhimurium observed
in the same transcriptome analysis [44].
The utilisation of glucose by S. Typhimurium (Fig. 5A and Fig.
S1) residing in the membrane-surrounded SCV is rather
unexpected if one assumes that glucose has to be transported
from the host cells’ cytosol across the SCV membrane to reach the
bacteria. Possibly, the endosomal SGLT1 as major glucose
transporter of Caco-2 cells [33] may fuse with the SCV membrane
thus providing sufficient amounts of [U-13C6]glucose to the SCV
in the Caco-2 cells. The glucose concentration in the SCV - at
least of some host cells - seems to be even high enough to activate
non-PTS glucose transporters of S. Typhimurium [15].
In all glucose uptake mutants, fewer amino acids acquire 13C-
label. The incorporation rates are highly reduced and the 13C-
isotopologue profiles are different for most amino acids as compared
to the data from the respective wild-type strains. This change is
apparently accompanied by an increased uptake of amino acids
from the host cells (cf. models A and B in Fig. 5 and Figs. S1 and S2).
Significantly enhanced degradation of amino acids in these mutants
does not seem to occur since the 13C-prelabelled amino acids taken
from the host cells retain their (host cell)-specific 13C-isotopologue
patterns in the bacteria, suggesting that these amino acids are
directly incorporated into protein without significant metabolic
turnover. The 13C-isotopologue patterns of the amino acids de novo
synthesised in the mutants rather suggest that they now preferen-
tially utilise 13C3-substrates (presumably glycerol, pyruvate or
lactate) generated in the host cells from [U-13C6]glucose (model B
in Fig. 5 and Fig. S2). Carbon compounds (mainly) degraded to
13C2-acetyl-CoA, such as fatty acids can be excluded as glucose
substitute on the basis of the observed 13C-isotopologue patterns of
certain amino acids, especially Ala. Even the three enterobacterial
wild-type strains may use with a strain-dependent extent 13C3-
substrates in addition to glucose, since they apparently rely (in part)
on gluconeogenesis which especially becomes evident by the 13C-
isotopologue pattern of Ser.
By our experimental approach (we analyse the bacterial
metabolism only at one time point, i.e. 6.5 or 8.5 h post infection,
respectively), we cannot rigorously distinguish whether the
intracellular bacterial wild-type strains metabolise these carbon
substrates simultaneously or successively. However, external
glucose appears to be present in excess throughout the infection
period (less than 10% of the external glucose is consumed at the
time when the intracellular bacteria are harvested). For this
reason, simultaneous utilisation of glucose and a 13C3-substrate
seems to be rather likely.
The largest portion of all amino acids in both types of
intracellular bacteria (cytosolic and phagosomal) is unlabelled,
indicating that most amino acids are imported from the host cells.
For S. Typhimurium, this fact shows that amino acids as anabolic
monomers can also be efficiently transported across the membrane
of the SCV. These amino acids are probably mainly taken up by
the host cells from the culture medium (containing all amino acids
except Ala) but may in part also originate from unlabelled host cell
protein by proteolytic turnover (see e.g. Ala). The latter possibility
is also suggested by the observation that substantial amounts of
host cell-derived 13C-labelled (‘‘non-essential’’) amino acids are
imported into the intracellular bacteria when the host cell protein
is prelabelled with [U-13C6]glucose for several generations prior to
infection. Surprisingly, even amino acids ‘‘essential’’ for the host
cells, like Ile, Leu, Phe, Tyr are not or only to a small part de novo
synthesised by the intracellular bacteria (as judged by the missing
or only low 13C-label in these amino acids isolated from the
bacteria) suggesting that even these amino acids (present in the
culture medium) are transported through the host cells into the
intracellular bacteria. However, there are strain-specific differenc-
es between the three enterobacterial wild-type strains and their
glucose transport mutants in the ratio of the amino acids de novo
synthesised and those taken up from the host cells. From these
differences one may conclude that the utilisation of energy-rich
glucose by the intracellular bacteria allows increased de novo
synthesis of amino acids (possibly also other anabolic monomers)
(model A in Fig. 5 and Fig. S1), while consumption of the less
energy-rich C3-substrates needs increased uptake of amino acids
from the host cells (model B in Fig. 5 and Fig. S2). This balance
between the bacterial anabolic metabolism and the utilised carbon
source may be the reason for the still relatively efficient
intracellular replication of the glucose uptake mutants. This
metabolic flexibility may also be crucial for the survival and
persistence of S. Typhimurium during systemic infections in mice
where the bacteria are encountering conditions with varying
nutrient supply [16,17,46,47].
Finally, the infection of the Caco-2 host cells neither by the
EIEC strains nor the S. Typhimurium isolate causes significant
changes in the carbon metabolism of the host cell as indicated by
the unchanged 13C-patterns of the amino acids deriving from
intermediates of glycolysis (Ala, Ser, Gly) or the TCA cycle (Glu,
Pro, Asp). This is different to recent findings in mammalian cells
infected with human cytomegalovirus (HCMV) [48] or Chlamydia
pneumoniae [49]. Infection with HCMV markedly up-regulates flux
through much of the central carbon metabolism, including
glycolysis and the TCA cycle of infected MRC-fibroblasts. C.
pneumoniae has an additive effect on hypoxia-inducible factor-1
alpha (HIF-1a) stabilization resulting in enhanced glucose uptake
of Hep-2 cells during the early phase of infection.
In conclusion, the data indicate that glucose is a preferred
carbon source for the intracellular metabolism of Escherichia coli
(EIEC HN280) and Salmonella enterica Serovar Typhimurium isolate
14028. EIEC 4608-58 also uses glucose but appears to simulta-
neously utilise a C3-substrate, probably glycerol. In all strains
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under study, the prime carbon source glucose can be replaced, if it
becomes unavailable, by alternative C3-substrates providing less
energy. The use of these alternative low-energy nutrients seems to
be counterbalanced by an increased uptake of amino acids (and
possibly also of other anabolic monomers) from the host cells.
Our experiments are done at an external glucose concentration
resembling the physiological concentrations in the human blood
and the intestines. However, one should keep in mind that our
results are obtained with a tumour cell line as a model host cell.
Tumour cells are known to exhibit a specific metabolism which is
characterise d by an increased uptake of glucose and by enhanced
glycolysis (‘‘Warburg-effect’’ - for a recent review see [43]). Only
further studies with actual target cells, tissues and animals will
show whether our conclusions drawn from these model studies are
also valid under infection conditions.
Materials and Methods
Bacterial strains and cell line
EIEC HN280 and EIEC 4608-58 were gifts from M. Nicoletti
(Chieti, Italy) and P. Sansonetti (Paris, France) [1,50]. S.
Typhimurium 14028 was obtained from M. Hensel (Erlangen,
Germany). Extra- and intracellular growth properties of these
strains and mutants are summarised in Table S2. The Caco-2 cell
line (ACC 169) was obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ, Braunschweig,
Germany). Caco-2 cells were cultured at 37uC and 5% CO2 in
RPMI 1640 medium supplemented with 10% FCS.
Bacterial growth conditions prior to infection
The EIEC strains were grown overnight in 20 ml Tryptic Soy
Broth (TSB) at 30uC and then diluted 1:100 (v/v) in 20 ml of fresh
TSB and further incubated for 2 h at 37uC with aeration. An
overnight culture of Stm 14028 grown in 20 ml LB with 0.5%
NaCl at 37uC was diluted 1:100 (v/v) into 20 ml of fresh LB with
1% NaCl and further shaken for 2.5 h at 37uC. When the cultures
reached a late logarithmic growth phase (OD600<1), bacteria were
diluted in RPMI 1640 containing 10% FCS and added to the
Caco-2 cells at different multiplicities of infection (MOI) (see
below).
Infection of Caco-2 cells and 13C-labelling
16107 cells were seeded into 20 ml cell culture medium in a
175 cm2 cell culture flask and grown for 2 days to obtain a 90%
confluent cell layer containing about 26107 cells. Ten flasks were
used in the infection experiments for each strain. For infection, the
culture medium was replaced by 20 ml of RPMI 1640 medium
containing 10% FCS and the bacteria. Due to different invasion
and replication rates of the bacteria, the MOI was adjusted to 20
bacteria per Caco-2 cell (for the EIEC HN280 wild-type strain and
the isogenic DuhpT mutant) and to 100 (for all other strains) to
obtain a total of approximately 108 colony forming units (cfu) for
EIEC 4608-58 and 109 cfu for EIEC HN280 and Stm 14028 at the
time point of harvest. Infection was allowed to proceed for 1 h.
Then, the medium was withdrawn and replaced by RPMI 1640
medium with 10% FCS containing 100 mg/ml gentamicin to kill
extracellular bacteria prior to 13C-labelling. This was defined as
time point zero hour post infection (h p.i.). After 30 min
incubation, this medium was again replaced by fresh RPMI
1640 medium containing 10% FCS, 100 mg/ml gentamicin and
10 mM [U-13C6]glucose. After 30 min, the gentamicin concen-
tration was lowered to 20 mg/ml. The infected cells were washed
with 10 ml of ice-cold PBS 6.5 h p.i. (for the two EIEC strains) or
8.5 h p.i. (for Stm 14028), and lysed in 10 ml of ice-cold distilled
water containing 0.1% TritonX-100, 20 mM Na-azide, 5 mg/ml
tetracycline and 50 mg/ml chloramphenicol for 20 min. Host cell
debris and nuclei were removed by three centrifugation steps at
2006g for 5 min at 4uC. The supernatant containing the bacteria
and the soluble host cell material was centrifuged at 55006g and
4uC for 15 min to pellet the bacteria. The resulting supernatant
was stored at 280uC and used as probe for the analysis of the host
cell amino acids (derived from soluble host cell protein). The
bacteria were washed with 5 ml of RIPA-buffer (150 mM NaCl,
50 mM Tris, 0.1% SDS, 0.5% deoxycholate, 1% Igepal non-idet
P-40) and centrifuged again. The resulting pellet was resuspended
in 500 ml of PBS and stored at 280uC. This fraction was used as
probe for the analysis of the 13C-labelled bacterial amino acids.
The contamination of the host cell protein fraction with bacterial
proteins and vice versa was less than 10% on the basis of the
differential 13C-labelling patterns.
Determination of glucose consumption by the host cells
and the intracellular bacteria with 14C-labelled glucose
Infection of Caco-2 cells with the three enterobacterial wild-type
strains was carried out as described above. After the internaliza-
tion period the remaining extracellular bacteria were killed by
treatment with 100 mg/ml gentamicin (0 h p.i.) for 30 min; then
the medium was replaced by 20 ml fresh RPMI 1640 containing
10% FCS, 20 mg/ml gentamicin and 200 mmol [U-14C]glucose
(specific activity, 0.5 MBq/mmol). The infected host cells were
further incubated for 6 h (for both EIEC strains) or 8 h (for Stm
14028). Thereafter, the cells were washed 4 times with 15 ml PBS,
lysed as described above, and the cfu were determined by plating
serial dilutions on LB-agar plates. Host cell and bacterial fractions
were separated as described above. Bacteria were resuspended in
1 ml PBS and the cfu were determined again. 14C-Label in each
fraction was measured in a scintillation counter and the
consumption of 14C-glucose by the host cells and the bacteria
was calculated (on a molar basis) by the incorporated 14C-label.
13C-Isotopologue profiling
Bacterial and host cell protein fractions were hydrolyzed with 6
M HCl for 24 h at 105uC and the resulting amino acids were
converted into their tert-butyl-dimethylsilyl (TBDMS)-derivatives
as described earlier [30]. 13C-Excess and the isotopologue
composition was determined as described earlier [30,51] using a
GC/MS Shimadzu QP 2010 Plus.
Supporting Information
Figure S1 Metabolic model for enteroinvasive Escherichia coli
(EIEC HN280 and EIEC 4608-58) and Salmonella enterica Serovar
Typhimurium (Stm 14028) wild-type strains replicating in Caco-2
cells in the presence of 10 mM [U-13C6]glucose. The bacteria are
indicated by the large boxes. Host cell metabolites and reactions
are shown outside these boxes. Contiguous 13C-label is indicated
by red bars. Single labelled isotopologues are indicated by red
dots. Metabolic flux observed under the various conditions is
indicated by blue arrows. The relative flux rates (on the basis of the
detected 13C-enrichments in amino acids) are symbolised by the
widths of the arrows. 13C-enriched amino acids detected are
shown in boxes. The numbers indicate the molar contributions (%)
of the major 13C-isotopologues detected by MS. The positional
13C-label distributions (as indicated by the bars and dots) are
predicted on the basis of the metabolic reactions in the model.
Glucose is utilized by the Entner-Doudoroff pathway. Notably,
degradation of [U-13C6]glucose by glycolysis or the pentose
phosphate pathway leads to identical labelling patterns. In EIEC
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4608-58, C3-compounds are utilised in addition to glucose
(indicated by the green arrows). The labelling patterns detected
in amino acids suggest that the citrate cycle is mainly used for the
formation of alpha-ketoglutarate and that oxaloacetate mainly
derives by PEP carboxylation.
Found at: doi:10.1371/journal.pone.0010586.s001 (16.52 MB
TIF)
Figure S2 Metabolic model for delta ptsG, manXYZ, uhpT
mutants (impaired in the uptake of glucose and glucose 6-
phosphate) of enteroinvasive Escherichia coli (EIEC HN280 and
EIEC 4608-58) and Salmonella enterica Serovar Typhimurium (Stm
14028) replicating in Caco-2 cells in the presence of 10 mM
[U-13C6]glucose. The bacteria are indicated by the large boxes.
Host cell metabolites and reactions are shown outside these boxes.
Contiguous 13C-label is indicated by red bars. Single labelled
isotopologues are indicated by red dots. Metabolic flux observed
under the various conditions is indicated by blue arrows. The
relative flux rates (on the basis of the detected 13C-enrichments in
amino acids) are symbolised by the widths of the arrows. 13C-
enriched amino acids detected are shown in boxes. The numbers
indicate the molar contributions (%) of the major 13C-isotopolo-
gues detected by MS. The positional 13C-label distributions (as
indicated by the bars and dots) are predicted on the basis of the
metabolic reactions in the model. This model is based on the lack
of efficient glucose uptake. In this case, intracellular metabolism is
shifted to an increased uptake of C3-compounds which may be
shuffled into the central carbon metabolism at the level of
pyruvate. alpha-Ketoglutarate as well as oxaloacetate are derived
in this case from the citrate cycle. Labelling patterns due to two
rounds of citrate cycling are given in purple. Under these
conditions, amino acids are imported from the host cells more
efficiently (indicated by the arrow widths).
Found at: doi:10.1371/journal.pone.0010586.s002 (14.04 MB
TIF)
Table S1 Composition of the standard RPMI 1640 medium
used in the present study. (Gibco: http://www.invitrogen.com/
site/us/en/home/support/Product-Technical-Resources/media_
formulation.116.html).
Found at: doi:10.1371/journal.pone.0010586.s003 (0.06 MB
DOC)
Table S2 Generation times of the studied enterobacterial
pathogens during extra- and intracellular growth. The doubling
times (DT in min) during growth of the bacteria in RPMI 1640,
supplemented with 10 mM glucose (Glc), mannose (Man) or
glucose 6-phosphate (Glc6P), or in Caco-2 cells were determined
by measuring the bacterial cell density (at OD600) and the colony
forming units (cfu), respectively. Also shown (right to the doubling
times) are the highest bacterial densities reached during growth.
Note that there is a low growth background of about OD600 =
0.2 even in the absence (w/o) of Glc, Man or Glc6P. Doubling
times during infection of Caco-2 cells were averaged from time
point 1 to 6 h post infection (p.i.). for the EIEC strains and from 0
to 8 h p.i. for Stm 14028. The construction of the mutants and
further details of their properties are published in [32].
Found at: doi:10.1371/journal.pone.0010586.s004 (0.06 MB
DOC)
Table S3 13C-Excess (%) per C-atom in amino acids from
experiments a-b, for details see Figure 2.
Found at: doi:10.1371/journal.pone.0010586.s005 (0.10 MB
DOC)
Table S4 13C-Isotopologue abundance of amino acids from all
experiments in mol%. The labelling pattern is given in terms of
XY-groups (Ro¨misch-Margl et al., 2007). This notation is based on
digits for each C-atom. The first digit represents C-1, the second
C-2, etc.; 1 signifies 13C, 0 signifies 12C, and X and Y signify either
13C or 12C. While the labelling status of X is totally undefined, the
overall number of 13C labelled atoms of Y is known and written
outside the brackets. Two independent labelling experiments were
analyzed if not indicated otherwise.
Found at: doi:10.1371/journal.pone.0010586.s006 (1.38 MB
DOC)
Table S5 13C-Excess (%) per C-atom in amino acids from
experiments a-n, for details see Figure 4.
Found at: doi:10.1371/journal.pone.0010586.s007 (0.04 MB
DOC)
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